Workflow
证券代码:603707 证券简称:健友股份 公告编号:2025-071 债券代码:113579 债券简称:健友转债

Group 1 - The company, Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd., has approved a stock repurchase plan with a total fund amount between RMB 20 million and RMB 40 million, with a maximum repurchase price of RMB 18.75 per share [2] - The repurchased shares will be used for employee stock ownership plans or equity incentives, and the implementation period is within 12 months from the approval date [2] - As of August 31, 2025, the company has repurchased a total of 880,000 shares, accounting for 0.05% of the total share capital, with a total payment of RMB 10.2207 million [3] Group 2 - The company will comply with relevant regulations and guidelines during the repurchase period and will make repurchase decisions based on market conditions [5] - The company is committed to timely information disclosure regarding the progress of the stock repurchase [5]